Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print March 14, 2007
DOI: 10.2337/db06-1727

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1727v1
56/6/1686    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueno, A.
Right arrow Articles by Yang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueno, A.
Right arrow Articles by Yang, Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Transient upregulation of IDO in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes

Aito Ueno1, Suzanne Cho1, Lu Cheng1, Jianxiong Wang1, Sheng Hou1, Hiroko Nakano1, Pere Santamaria2, and Yang Yang1

1Julia McFarlane Diabetes Research Centre, Department of Biochemistry and Molecular Biology
2Department of Microbiology and Infectious Diseases, Faculty of Medicine, The University of Calgary, Canada

Correspondence: yyang{at}ucalgary.ca

Objective:: Pregnancy induces a state of immunological tolerance that aims at suppressing immune responses against the fetus and has been linked to temporal remission of pre-existing autoimmune disorders. To understand the mechanisms of this reversible immune regulation, we investigate the role of a key pregnancy hormone, human chorionic gonadotropin (hCG), in immune tolerance against autoimmune type 1 diabetes in nonobese diabetic (NOD) mice.

Research Design and methods:: We injected hCG into cytokine gene deficient NOD mice, and evaluated the effects of hCG administration on T cells and dendritic cells (DCs).

Results and conclusions:: We show that administration of hCG to NOD mice inhibits both the activation of diabetogenic CD4+ and CD8+ T cells, in vitro and in vivo, and the progression of T1D by upregulating the expression of indoleamine 2,3-dioxygenase (IDO) in dendritic cells (DCs). IDO upregulation is transient and declined shortly after hCG withdrawal. DC-depletion restores the diabetetogenic activity of splenic T cells from hCG-treated mice, and inhibition of IDO activity by 1-methyl-tryptophan (1-MT) abrogates the hCG-induced T cell suppression and resistance to T1D. We propose that hCG-induced upregulation of IDO in DCs plays a major role in pregnancy-associated resistance to autoimmunity.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
H. Fujiwara
Reply: Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome
Hum. Reprod., November 1, 2007; 22(11): 3042 - 3043.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.